Cargando…
Benefits of resistant starch type 2 for patients with end-stage renal disease under maintenance hemodialysis: a systematic review and meta-analysis
Background: Resistant starch type 2 (RS2) has been documented to regulate gut microbiota and to improve the clinical outcomes of several diseases. However, whether RS2 may benefit patients with end-stage renal disease under maintenance hemodialysis (MHD) remains unknown. Methods: We conducted a syst...
Autores principales: | Jia, Linpei, Dong, Xingtong, Li, Xiaoxia, Jia, Rufu, Zhang, Hong-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797550/ https://www.ncbi.nlm.nih.gov/pubmed/33437217 http://dx.doi.org/10.7150/ijms.51484 |
Ejemplares similares
-
Correspondence: Guillain-Barré syndrome and hemorrhagic fever with renal syndrome
por: Jia, Linpei, et al.
Publicado: (2019) -
Frequency of Intradialytic Complications in Patients of End-Stage Renal Disease on Maintenance Hemodialysis
por: Ali, Muhammad, et al.
Publicado: (2021) -
Safety and Tolerability of Remdesivir in Patients with End-stage Renal Disease on Maintenance Hemodialysis
por: Shah, Maulin K, et al.
Publicado: (2022) -
Advances in antibiotic therapy in the critically ill
por: Jia, Rufu, et al.
Publicado: (2016) -
Effect of maintenance hemodialysis on diastolic left ventricular function in end‐stage renal disease
por: Duran, Mustafa, et al.
Publicado: (2010)